Intelligence Platform

Patents

Browse 405 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9839688

Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment

Provectus Pharmatech, Inc. · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820955

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA co

The Regents of the University of California · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9808524

Combination of local and systemic immunomodulative therapies for melanoma and liver cancer

Provectus Pharmatech, Inc. · Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9782437

Methods and compositions for targeted cleavage and recombination

Sangamo Therapeutics, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765147

Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer

Five Prime Therapeutics, Inc. · Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9730989

Compositions and methods for combination therapy with dengue virus and dendritic cells

PrimeVax Immuno-Oncology · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9731011

Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and int

EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700561

Drug combinations and uses in treating a coughing condition

Infirst Healthcare Limited · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9694071

Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

TG Therapeutics, Inc. · Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675618

Drug combinations and uses in treating a coughing condition

Infirst Healthcare Limited · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9636334

Combination of lenalidomide and polypeptide construct, and uses thereof

TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629899

Targeted cargo protein combination therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9597302

Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibril

Heart Rhythm Solutions, Inc. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9572809

Combination therapy to treat Mycobacterium diseases

SPERO TRINEM, INC. · Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9561245

Combination treatments for melanoma

The Board of Regents of the University of Texas System · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9556113

Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment

SOUTH DAKOTA BOARD OF REGENTS · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9532994

Agents and methods for enhancing bone formation by oxysterols in combination with bone mor

The Regents of the University of California · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9463166

Controlled release compositions comprising a combination of isosorbide dinitrate and hydra

RECRO GAINESVILLE LLC · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9452175

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9421254

Immunostimulatory combinations of TLR ligands and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9375475

Combination immunotherapy for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359313

Use of metformin in combination with a glucokinase activator and compositions comprising m

VTV THERAPEUTICS LLC · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9320789

Combinations of gene deletions for live attenuated shigella vaccine strains

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9314465

Drug combinations and uses in treating a coughing condition

Infirst Healthcare Limited · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted